Journal of Jilin University(Medicine Edition) ›› 2026, Vol. 52 ›› Issue (4): 881-892.doi: 10.13481/j.1671-587X.20260401
• Research in basic medicine • Next Articles
Received:2025-08-12
Accepted:2025-12-02
Online:2026-07-28
Published:2026-07-27
Contact:
Jiaxin LI
E-mail:jiaxinli2020@pku.edu.cn
CLC Number:
Jiaxin LI,Xinyang ZHANG. Bioinformatics analysis on effect of chemokine receptor 6 expression on tumor immune microenvironment and its impact on regulatory T lymphocyte function[J].Journal of Jilin University(Medicine Edition), 2026, 52(4): 881-892.
Tab.1
CXCR6 knockdown shRNA sequences"
| Sequence ID | Sense(5'-3') | Anti-sense(5'-3') |
|---|---|---|
| CXCR6-KD1# | CCGGGCGCATTCTCATGGAGAAGTTCTCGAGAACTTCTCCATGAGAATGCGCTTTTT | AAAAAGCGCATTCTCATGGAGAAGTTCTCGAGAACTTCTCCATGAGAATGCGCCCGG |
| CXCR6-KD2# | CCGGGCTTGCTCATCTGGGTGATATCTCGAGATATCACCCAGATGAGCAAGCTTTTT | AAAAAGCTTGCTCATCTGGGTGATATCTCGAGATATCACCCAGATGAGCAAGCCCGG |
| CXCR6-KD3# | CCGGCTCACCATGATTGTCTGCTATCTCGAGATAGCAGACAATCATGGTGAGTTTTT | AAAAACTCACCATGATTGTCTGCTATCTCGAGATAGCAGACAATCATGGTGAGCCGG |
| CXCR6-KD4# | CCGGCTGAGGACAATTCCAAGACTTCTCGAGAAGTCTTGGAATTGTCCTCAGTTTTT | AAAAACTGAGGACAATTCCAAGACTTCTCGAGAAGTCTTGGAATTGTCCTCAGCCGG |
| [1] | SAKAGUCHI S, MIYARA M, COSTANTINO C M, et al. FOXP3⁺ regulatory T cells in the human immune system[J]. Nat Rev Immunol, 2010, 10(7):490-500. |
| [2] | DENG L, CHEN N Y, LI Y, et al. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer[J]. Biochim Biophys Acta BBA Rev Cancer, 2010, 1806(1): 42-49. |
| [3] | BAO N D, FU B, ZHONG X L, et al. Role of the CXCR6/CXCL16 axis in autoimmune diseases[J]. Int Immunopharmacol, 2023, 121: 110530. |
| [4] | MENG J, YANG Y L, LV J J, et al. CXCR6 expression correlates with radiotherapy response and immune context in triple-negative breast cancer-experimental studies[J]. Int J Surg, 2024, 110(8): 4695-4707. |
| [5] | 胡文露, 张盼盼, 贺玉杰, 等. 血清γ-谷氨酰转移酶水平与抗黑色素瘤分化相关基因5抗体阳性皮肌炎早期死亡的关联性[J]. 郑州大学学报(医学版), 2026, 61(3):166-168. |
| [6] | FRIDMAN W H, PAGÈS F, SAUTÈS-FRIDMAN C, et al. The immune contexture in human tumours: impact on clinical outcome[J]. Nat Rev Cancer, 2012, 12(4): 298-306. |
| [7] | MABROUK N, TRAN T, SAM I, et al. CXCR6 expressing T cells: Functions and role in the control of tumors[J]. Front Immunol, 2022, 13: 1022136. |
| [8] | LI L T, HUANG Y F, XUE R Z, et al. T cell-mediated mechanisms of immune-related adverse events induced by immune checkpoint inhibitors[J]. Crit Rev Oncol, 2025, 213: 104808. |
| [9] | LI T T, PAN J, CHEN H Q, et al. CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction[J]. Acta Pharm Sin B, 2022, 12(8): 3255-3262. |
| [10] | LIANG Z, TANG Z W, ZHU C J, et al. Intestinal CXCR6+ ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression[J]. Immunity, 2024, 57(6): 1306-1323.e8. |
| [11] | LESCH S, BLUMENBERG V, STOIBER S, et al. T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours[J]. Nat Biomed Eng, 2021, 5(11): 1246-1260. |
| [12] | LI T W, FAN J Y, WANG B B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer Res, 2017, 77(21): e108-e110. |
| [13] | 吴琴. PI16通过DOT1L影响CD4+CD25+Foxp3+调节性T细胞数量及功能参与类风湿关节炎发病的研究[D]. 南京:南京医科大学,2018. |
| [14] | PU J, LIU T, ZHOU Y, et al. T cells in cancer: mechanistic insights and therapeutic advances[J]. Biomark Res, 2025, 13: 97. |
| [15] | GAVIL N V, CHENG K, MASOPUST D. Resident memory T cells and cancer[J]. Immunity, 2024, 57(8):1734-51. |
| [16] | MA K, XU Y, CHENG H, et al. T cell-based cancer immunotherapy: opportunities and challenges[J]. Sci Bull, 2025, 70(11):1872-1890. |
| [17] | OLIVEIRA G, WU C J. Dynamics and specificities of T cells in cancer immunotherapy[J]. Nat Rev Cancer, 2023, 23:295-316. |
| [18] | STEIER Z, KIM EJY, AYLARD DA, et al. The CD4 versus CD8 T cell fate decision: A Multiomics-Informed perspective[J]. Annu Rev Immunol, 2024, 42(1):235-58. |
| [19] | GALASSI C, CHAN TA, VITALE I, et al. The hallmarks of cancer immune evasion[J]. Cancer Cell, 2024, 42(11):1825-63. |
| [20] | MADDEN M Z, RATHMELL J C. The complex integration of T-cell metabolism and immunotherapy[J]. Cancer Discov, 2021, 11(7):1636-43. |
| [21] | ZONG Y, DENG K, CHONG WP. Regulation of Treg cells by cytokine signaling and co-stimulatory molecules[J]. Front Immunol, 2024, 15:1387975. |
| [22] | CAO X, CAI S F, FEHNIGER T A, et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance [J]. Immunity, 2007 Oct.27(4): 635-646. |
| [23] | MARANGONI F, et al. Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop[J]. Cell, 184(15):3998-4015.e19. |
| [24] | ZAPPASODI R, SERGANOVA I, COHEN IJ, et al. CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours[J]. Nature, 2021, 591:652-658. |
| [25] | MOTOHASHI S, NISHIKAWA H. Regulatory T cells in the tumour microenvironment and their therapeutic targeting[J]. Nat Rev Clin Oncol, 2018, 15(5):329-346. |
| [26] | DI PILATO M, KFURI-RUBENS R, PRUESSMANN J N, et al.CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment[J]. Cell, 2021, 184(17):4512-4530. |
| [27] | KIM M J, SUN H J, SONG Y S, et al.CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer[J]. Sci Rep, 2019; (9):13288 |
| [28] | MIR H, KAPUR N, GALES D N, et al. CXCR6-CXCL16 axis promotes breast cancer by inducing oncogenic signaling[J]. Cancers, 2021, 13(14): 3568. |
| [29] | SUN Y K, LIN S Y, WANG H, et al. Regulatory role of PI16 in autoimmune arthritis and intestinal inflammation: implications for Treg cell differentiation and function[J]. J Transl Med, 2024, 22(1): 327. |
| [30] | NICHOLSON I C, MAVRANGELOS C, BIRD D R, et al. PI16 is expressed by a subset of human memory Treg with enhanced migration to CCL17 and CCL20[J]. Cell Immunol, 2012, 275(1/2): 12-18. |
| [31] | BROQUET A, GOURAIN V, GORONFLOT T, et al. Sepsis-trained macrophages promote antitumoral tissue-resident T cells[J]. Nat Immunol, 2024, 25(5): 802-819. |
| [1] | Feida YAN,Mingdi CHEN,Zhiwei LIANG. Inhibitory effect of TPX2 silencing on immune escape in non-small cell lung cancer A549 cells by regulating Wnt/β-catenin signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(4): 1011-1021. |
| [2] | Pingxu AN,Qi HUANG,Xinyu HONG. Research progress in immunotherapy and anti-angiogenic therapy under pituitary adenoma tumor microenvironment [J]. Journal of Jilin University(Medicine Edition), 2026, 52(4): 1170-1178. |
| [3] | Xiaohui LIANG,Wenna LIU,Jianbo ZHAO. Bioinformatic analysis on PAQR3 expression in hepatocellular carcinoma and its correlations with T lymphocyte infiltration, immune checkpoint genes, and patient survival [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 781-790. |
| [4] | Luyao WANG,Chenxi ZHAO,Jincheng DU,Linlin LIU. Research progress in effect of Toll-like receptor 7/8 on occurrence and development of tumor [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 264-271. |
| [5] | Zhimin LI,Mingge HUO,Longxue GUAN,Fanlin GU,Dandan LIANG,Zhuorui LIU,Guoqing WANG,Xingang GUAN. Biological properties of bacterial outer membrane vesicles surface-displaying PD-L1 nanobodies and their disrupting effects on PD-1/PD-L1 signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1407-1414. |
| [6] | Xiaoshuang HE,Lina XU,Mei CUI,Yu ZHAO,Bei WANG,Zheng HUANG,Yuchao WANG,Wenyan XIN,Chao WU. Effects of lncRNA DUXAP8 in lung cancer A549 cells-derived exosomes on lung cancer cell growth and its mechnism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 958-967. |
| [7] | Yuling GU,Cui ZHENG,Yunxian TANG. Inhibitory effect of silencing of circadian rhythm gene TIMELESS on immune escape of ovarian cancer SK-OV-3 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 653-662. |
| [8] | Shuo ZHANG,Yunxiu XIA,Weiwei CHEN,Hongliang DONG,Bingjie CUI,Cuilan LIU,Zhiqiang LIU,Fei WANG,Jing DU. Effect of over-expression of NR2F2 on biological behaviors of human ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 58-67. |
| [9] | Xi YANG,Qin YUAN,Lan YANG,Wenjie ZHANG. Bioinformatics analysis on PDE1B expression and prognosis of gastric cancer and tumor microenvironment [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1664-1676. |
| [10] | Lin CHEN,Limin YAN,Huaijie XING,Min CHEN,Xiaoyan LI,Chaosheng ZENG. Improvement effect of Xuebijing on brain tissue injury and Th17/Treg immune imbalance in cerebrospinal fluid in NMDA receptor encephalitis model mice [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 697-707. |
| [11] | Dehong ZHANG,Mingzhu ZHENG,Jiaqiu LI,Zhong LU. Bioinformatics analysis based on expressions of MSR1 mRNA and protein in pan-cancer tissue and its significance [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 425-439. |
| [12] | Zhiyuan XIAO,Bing SONG,Xinyu MA,Lianhui JIN,Tong ZHENG,Fang CHAI. Bioinformatics analysis on expression of apoptosis related gene CD44 in thyroid carcinoma tissue and its relationship with tumor invasion and immune cell infiltration [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 473-481. |
| [13] | Junjie HOU,Xuguang MI,Xiaonan LI,Xiaonan LI,Ying YANG,Xiaodan LU,Yanqiu FANG,Ningyi JIN. Establishment and evaluation of prognostic model of lung adenocarcinoma based on lactate metabolism gene [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1546-1554. |
| [14] | Qinghui WANG,Bo LI,Chuancui HU,Mingchao NIE,Xiaomei ZHENG. Effects of miR-107 on regulation of immune escape and taxol resistance of ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 734-743. |
| [15] | Ying ZHAO,Danyu ZHAO,Chao LIU. Bioinformatics analysis on prognostic evaluation value of TXNDC11 gene in pan-cancer and its immunity regulation [J]. Journal of Jilin University(Medicine Edition), 2022, 48(1): 142-153. |
|
||
